Coronavirus disease 2019 (COVID-19) had deleterious effects on patients with mental health problems and several studies have shown a spike in the rates of depression, insomnia, and post-traumatic stress disorder. Anxiety and insomnia rates have also increased among both the general public and health care professionals. Benzodiazepines are some of the most commonly used drugs in the treatment of anxiety and insomnia. However, benzodiazepines are also misused, abused alone, or abused in combination with other drugs. Lockdowns and social distancing have also had negative consequences on patients with mental health problems. We assessed the extent of benzodiazepine use during the pandemic and interpreted its effects in the future. We conducted a literature search using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) protocol and eight articles reviewed specifically reported worrying fluctuations in benzodiazepine use during the pandemic. We observed varied trends in the usage of benzodiazepines in various parts of the world. Some studies showed an increase in the consumption of benzodiazepine while others demonstrated a decrease in the prescription refills of benzodiazepine, which may be a result of gaps in mental health care. At this time, we can conclude that the current trend with benzodiazepine use is fluctuating and mental health professionals must continue to exercise caution before prescribing benzodiazepines. Future research is also warranted to be aware of the changing patterns and to avoid misuse and/or abuse at an epidemic level.

The coronavirus disease 2019 (COVID-19) pandemic has resulted in nationwide stay-at-home orders in an effort to slow the spread severely impacting the healthcare sector. Telepsychiatry provides a platform bridging the gap through advanced technologies connecting mental health providers and patients who need their services, overcoming previous barriers of great distances, lack of transportation, and even time constraints. The most obvious benefit is increased accessibility to mental healthcare, especially in underserved and remote areas where there is no easy access for in-person care. It is important to note that benefits are not limited to patients, but also allow clinicians greater flexibility in scheduling and reduced practice overhead costs, both of which aid with physician burnout and burden. Telepsychiatry during COVID-19 provides its own unique advantages over in-person visits. The risk of exposure to healthcare workers and patients receiving care is reduced, allowing immunocompromised patients to receive much-needed psychiatric care. Without the need to meet in person, self-isolating psychiatrists can still provide care, decreasing strain on their co-workers. Although telepsychiatry is relatively new, it has already exhibited considerable success in its effectiveness at treating psychiatric conditions and widespread corollary benefits. Telepsychiatric consults may be carried out synchronously and asynchronously, each having benefits and setbacks. Different mobile application interventions have been explored, which are available for the purpose of both monitoring/assessing patients and/or providing treatment. The scope of conditions these applications address is broad, from anxiety disorders to schizophrenia to depression. As promising and beneficial telepsychiatry may seem, it is necessary to recognize that building the program can be challenging. It involves adapting to new methods in medicine. We highlighted barriers to general telepsychiatry, the most prominent being technological literacy of both physician and patient, and possible negative effects of eliminating the in-person patient-doctor interaction.

Background: There is limited literature available showing the mental health burden among adolescents following cyberbullying. Objective: The aim was to evaluate the association between low mood and suicidality among cyberbullied adolescents. Method: A cross-sectional analysis of the data was performed among adolescents from the National Youth Risk Behavior Surveillance System. Responses from adolescents related to cyberbullying and suicidality were evaluated. Chi-square and mix-effect multivariable logistic regression analysis was performed to determine the association of cyberbullying with sadness/hopelessness and suicide consideration, plan, and attempts. Results: Of a total of 8274 adolescents, 14.8% of adolescents faced cyberbullying past year. There was a higher prevalence of cyberbullying in youths aged 15, 16, and 17 years (25%, 26%, 23%, respectively), which included more females than males (68% vs. 32%; p < 0.0001). Caucasians (53%) had the highest number of responses to being cyberbullied compared to Hispanics (24%) or African Americans (11%; p < 0.0001). There was an increased prevalence of cyberbullied youths, feelings of sadness/hopelessness (59.6% vs. 25.8%), higher numbers considering suicide (40.4% vs. 13.2%), suicide plan (33.2% vs. 10.8%), and multiple suicidal attempts in comparison to non-cyberbullied (p < 0.0001). On regression analysis, cyberbullied adolescents had a 155% higher chance of feeling sad and hopeless [aOR = 2.55; 95%CI = 2.39–2.72] and considered suicide [aOR = 1.52 (1.39–1.66)] and suicide plan [aOR = 1.24 (1.13–1.36)]. Conclusion: In our Study, cyberbullying was associated with negative mental health outcomes. Further research is warranted to examine the impact of cyberbullying among adolescents and guiding the policies to mitigate the consequences.